| Literature DB >> 30841905 |
Min Feng1, Tingting Xie1,2, Yuanfang Li1,2, Nan Zhang1, Qiuyuan Lu1, Yaohong Zhou1, Meiqing Shi3, Jingchen Sun4, Xiquan Zhang5,6.
Abstract
Avian leukosis virus subgroup J (ALV-J) infection can cause tumors and immunosuppression in infected chickens. Macrophages play a central role in host defense against invading pathogens. In this study, we discovered an interesting phenomenon: ALV-J replication is weakened from 3 hours post-infection (hpi) to 36 hpi, which was verified using Western blotting and RT-PCR. To further investigate the interaction between ALV-J and macrophages, transcriptome analysis was performed to analyze the host genes' function in chicken primary monocyte-derived macrophages (MDM). Compared to the uninfected control, 624 up-regulated differentially expressed genes (DEG) and 341 down-regulated DEG at 3 hpi, and 174 up-regulated DEG and 87 down-regulated DEG at 36 hpi were identified in chicken MDM, respectively. ALV-J infection induced strong innate immune responses in chicken MDM at 3 hpi, instead of 36 hpi, according to the analysis results of Gene Ontology and KEGG pathway. Importantly, the host factors, such as up-regulated MIP-3α, IL-1β, iNOS, K60, IRG1, CH25H, NFKBIZ, lysozyme and OASL were involved in the host defense response during the course of ALV-J infection. On the contrary, up-regulated EX-FABP, IL4I1, COX-2, NFKBIA, TNFAIP3 and the Jak STAT pathway inhibitors including CISH, SOCS1 and SOCS3 are beneficial to ALV-J survival in chicken macrophages. We speculated that ALV-J tropism for macrophages helps to establish a latent infection in chicken MDM from 6 to 36 hpi. The present study provides a comprehensive view of the interactions between macrophages and ALV-J. It suggests the mechanisms of defense of chicken macrophages against ALV-J invasion and how ALV-J escape the host innate immune responses.Entities:
Mesh:
Year: 2019 PMID: 30841905 PMCID: PMC6404279 DOI: 10.1186/s13567-019-0638-y
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1Detection of ALV-J replication in chicken MDM from 3 hpi to 36 hpi. A PCR detection with DNA template and ALV-J specific primer. All samples extracted from 3 hpi to 36 hpi produced specific 545 bp fragment. B RT-PCR detection with cDNA template and ALV-J specific primer. C Western blotting analysis shows that samples extracted from 3 hpi produced obvious specific ALV-J envelope protein blots, but the protein blots became weaker at 6 hpi and tended to disappear at 12 to 36 hpi.
Figure 2DEG in chicken MDM infected with ALV-J at 3 hpi and 36 hpi. Venn diagrams of up-regulated DEG (A) and down-regulated DEG (B) at 3 hpi and 36 hpi from chicken MDM. C Venn diagrams of up-regulated DEG at 3 hpi and down-regulated DEG at 36 hpi in chicken MDM. D Venn diagrams of down-regulated DEG at 3 hpi compared up-regulated DEG at 36 hpi in chicken MDM.
Figure 3Gene ontology (GO) terms analysis of DEG expressed in ALV-J-infected MDM. Representative GO terms of up-regulated DEG in the ALV-J-infected MDM at A 3 hpi and B 36 hpi. Down-regulated DEG enriched in the representative GO terms of ALV-J-infected MDM at C 3 hpi and D 36 hpi.
Figure 4KEGG pathways in ALV-J-infected MDM. KEGG pathways of up-regulated DEG expressed in ALV-J-infected MDM at A 3 hpi and B 36 hpi. C Down-regulated DEG enriched in KEGG pathways of ALV-J-infected MDM at 3 hpi.
Figure 5Heatmap of immune-related DEG at different time points after ALV-J infection. DEG with similar expressed patterns were clustered and are displayed in a heatmap format. Color intensity corresponds to relative expression level normalized according to log2 fold change. A Selected immune-related DEG from 3 hpi and 36 hpi. Red, up-regulated DEG; blue, down-regulated DEG. B ISG expression in MDM at 3 hpi and 36 hpi. Red, up-regulated ISG; purple, down-regulated ISG.
Figure 6Validation of RNA-Seq data by qPCR. DEG were selected at (A) 3 hpi and (B) 36 hpi. qPCR results were represented using relative expression value. RNA-seq value is log2(foldchange) values of DEG. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 7Overexpression of , , and could inhibit ALV-J replication. MDM cells were transfected with pCMV-K60, pCMV-IRG1, pCMV-OASL, pCMV-CH25H and infected with ALV-J strain SCAU-HN06 at 24 post-transfection. MDM cells transfected with pCMV-EGFP as a control. A SCAU-HN06 strain envelop protein was measured by Western blot at 3 hpi. B The level of SCAU-HN06 strain envelop protein was analyzed by Image Studio Ver 5.2 (Odyssey Fc). C The expression of SCAU-HN06 env gene was measured by qPCR at 3 hpi. *p < 0.05, **p < 0.01.
Figure 8Overexpression of , -, and could enhance ALV-J replication. MDM cells were transfected with plasmids including EGFP, CISH, EX-FABP, IL4I1 and SOCS3 and infected with SCAU-HN06 at 24 post-transfection. A, B The level of SCAU-HN06 strain envelop protein was detected by Western blot at 3 hpi and analyzed by Image Studio Ver 5.2 (Odyssey Fc). (C) The expression of SCAU-HN06 env gene was detected by qPCR at 3 hpi. *p < 0.05, **p < 0.01.
The DEG listed involved in the pattern recognition receptor pathway and Jak-STAT signaling pathway in ALV-J-infected MDM
| Gene ID | Gene name | Biological processes | log2 (fold change) 3 hpi, 36 hpi | Source of DEG |
|---|---|---|---|---|
| ENSGALG00000007015 | CD40 | ① | 3.89259, – | 3 hpi |
| ENSGALG00000015474 | CD80 | ① | 1.74169, – | 3 hpi |
| ENSGALG00000011389 | TRAF3 | ①, ③ | 3.76105, – | 3 hpi |
| ENSGALG00000007932 | TRAF6 | ①, ②, ③ | 1.27085, – | 3 hpi |
| ENSGALG00000009014 | TRAF2 | ③ | 2.74956, 1.13451 | 3 hpi and 36 hpi |
| ENSGALG00000000951 | CCL5 | ①, ④ | 4.20314, – | 3 hpi |
| ENSGALG00000013356 | IKBKE | ①, ③, ④ | 2.38933, 1.06398 | 3 hpi and 36 hpi |
| ENSGALG00000014297 | IRF7 | ①, ③, ④ | 4.51047, – | 3 hpi |
| ENSGALG00000000534 | IL1β | ①, ②, ④ | 8.57939, – | 3 hpi |
| ENSGALG00000011668 | K60 (IL8L1) | ①, ②, ③ | 7.00993, – | 3 hpi |
| ENSGALG00000026098 | IL8 (IL8L2) | ①, ②, ③ | 5.96016, 1.67045 | 3 hpi and 36 hpi |
| ENSGALG00000008612 | MAPK11(p38Beta) | ①, ②, ③ | 1.56955, – | 3 hpi |
| ENSGALG00000004735 | MAP2K3(MKK3) | ① | 1.62121, – | 3 hpi |
| ENSGALG00000007356 | MAP3K8 | ① | 3.52264, – | 3 hpi |
| ENSGALG00000012304 | NFKB1 | ①, ②, ③, ④ | 3.76626, – | 3 hpi |
| ENSGALG00000003428 | PIK3R2 | ① | 1.30282, – | 3 hpi |
| ENSGALG00000021573 | PIK3R5L | ① | 2.7941, 1.12565 | 3 hpi and 36 hpi |
| ENSGALG00000026167 | PIK3R5 | ① | 2.77632, 1.13829 | 3 hpi and 36 hpi |
| ENSGALG00000001077 | TIRAP | ① | 2.04202, – | 3 hpi |
| ENSGALG00000013861 | TNFAIP3 (A20) | ② | 3.42548, – | 3 hpi |
| ENSGALG00000017186 | BIRC2 | ② | 3.67041, – | 3 hpi |
| ENSGALG00000007874 | IL18 | ②, ④ | 2.72387, 1.6161 | 3 hpi and 36 hpi |
| ENSGALG00000015899 | RIPK2 | ② | 4.27785, – | 3 hpi |
| ENSGALG00000021325 | RIPK3 | ② | 3.04709, – | 3 hpi |
| ENSGALG00000017485 | TLR1A | ① | –, 1.47044 | 36 hpi |
| ENSGALG00000027093 | TLR1B | ① | –, 1.10129 | 36 hpi |
| ENSGALG00000016590 | TLR7 | ① | –, 1.15464 | 36 hpi |
| ENSGALG00000008166 | TLR15 | 2.10934, 1.89122 | 3 hpi and 36 hpi | |
| ENSGALG00000027864 | NFKBIA | 2.10466, 1.14704 | 3 hpi and 36 hpi | |
| ENSGALG00000005653 | NFKB2 | 2.8071, 1.41077 | 3 hpi and 36 hpi | |
| Jak-STAT signaling pathway | ||||
| ENSGALG00000002260 | CISH (CIS) | 2.58373, – | 3 hpi | |
| ENSGALG00000003282 | STAT5B | 1.29572, – | 3 hpi | |
| ENSGALG00000007158 | SOCS1 | 4.22098, – | 3 hpi | |
| ENSGALG00000027786 | SOCS3 | 4.08564, 3.14348 | 3 hpi and 36 hpi | |
| ENSGALG00000010016 | SOCS5 | −1.07644, – | 3 hpi | |
DEG with significant changes in expression at 3 hpi and 36 hpi
| Gene ID | Gene name | 3 hpi FPKM (J/NC), log2(foldchange) | 36 hpi FPKM (J/NC), log2(foldchange) |
|---|---|---|---|
| ENSGALG00000003003 | MIP-3α (CCL20) | (2519.22/2.23788), 10.1366 | – |
| ENSGALG00000000534 | IL-1β | (3039.04/7.94481), 8.57939 | – |
| ENSGALG00000005069 | PTGS2 (COX-2) | (179.952/0.74049), 7.92492 | – |
| ENSGALG00000005693 | iNOS (NOS2) | (1289.62/6.00488), 7.7466 | – |
| ENSGALG00000011668 | K60(IL8L1) | (2559.75/19.8609), 7.00993 | – |
| ENSGALG00000014182 | ADORA2B | (144.072/1.51003), 6.57606 | – |
| ENSGALG00000016286 | CXorf21 | (717.697/7.58374), 6.56432 | – |
| ENSGALG00000006352 | CH25H | (623.719/46.4632), 3.74674 | – |
| ENSGALG00000016919 | IRG1 | (5752.22/67.2951), 6.41747 | (77.9823/13.1535), 2.5677 |
| ENSGALG00000015346 | NFKBIZ | (1250.44/16.1651), 6.27342 | (12.6029/6.1146), 1.04343 |
| ENSGALG00000006337 | K123 | (491.778/8.8756), 5.79202 | (12.9952/1.95007), 2.73638 |
| ENSGALG00000000081 | IL4I1 | (119.384/3.37829), 5.14318 | (23.0818/0.794182), 4.86114 |
| ENSGALG00000017184 | MMP7 | – | (76.752/4.11625), 4.2208 |
| ENSGALG00000009963 | LYZ (lysozyme) | (821.232/74.5905), 3.46073 | (5524.5/62.4031), 6.46808 |
| ENSGALG00000024011 | EX-FABP | (679.788/93.0983), 2.86826 | (15805/51.4835), 8.26205 |
| ENSGALG00000027716 | HPS5 | (459.873/127.921), 1.84599 | (3600.15/52.3945), 6.1025 |
| ENSGALG00000013723 | OASL | (56.9902/11.452), 2.31511 | (6.0525/21.2826), − 1.81407 |
| ENSGALG00000000947 | FKBP51 | (59.357/13.3894), 2.14832 | (11.6466/48.2111), − 2.04946 |
| ENSGALG00000006562 | MCF2 (DBL) | (20.0391/9.42061), 1.08892 | (6.14223/13.7507), − 1.16268 |